CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | Smith Mark Douglas Director | Grant or award | +1,605 | 11,285 | ||
| 2026-08-05 | Cook Jennifer E. Director | Grant or award | +1,605 | 12,442 | ||
| 2026-08-05 | Hamill Laura Director | Grant or award | +1,605 | 8,538 | ||
| 2026-08-05 | McSharry Heather Ann Director | Grant or award | +1,605 | 20,054 | ||
| 2026-08-05 | Mulligan Seamus Director | Grant or award | +1,605 | 1,184,633 | ||
| 2026-08-05 | Winningham Rick E Director | Grant or award | +1,605 | 11,172 | ||
| 2026-08-05 | ENRIGHT PATRICK G Director | Grant or award | +1,605 | 22,984 | ||
| 2026-08-05 | COZADD BRUCE C Director | Grant or award | +1,605 | 362,287 | ||
| 2026-08-05 | LOVE TED W Director | Grant or award | +1,605 | 3,132 | ||
| 2026-08-05 | RIEDEL NORBERT G Director | Grant or award | +1,605 | 8,629 | ||
| 2026-08-03 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $252.98 | $1.5M | 360,682 |
| 2026-07-01 | COZADD BRUCE C Director | Sale 10b5-1 | −6,000 | $240.47 | $1.4M | 366,682 |
| 2026-06-30 | Johnson Philip L EVP & Chief Financial Officer | Shares withheld for taxes | −3,343 | $237.72 | $795K | 56,431 |
| 2026-06-30 | Pearce Samantha EVP, Chief Commercial Officer | Shares withheld for taxes | −2,527 | $237.72 | $601K | 47,911 |
| 2026-06-30 | Patil Neena M EVP & Chief Legal Officer | Shares withheld for taxes | −2,678 | $237.72 | $637K | 48,871 |
| 2026-06-30 | Iannone Robert EVP, Global Head of R&D & CMO | Shares withheld for taxes | −3,764 | $237.72 | $895K | 85,107 |
| 2026-06-30 | GALA RENEE D President & CEO | Shares withheld for taxes | −4,835 | $237.72 | $1.1M | 147,361 |
| 2026-06-15 | Smith Mark Douglas Director | Sale 10b5-1 | −1,157 | $230.55 | $267K | 9,680 |
| 2026-06-10 | Patil Neena M EVP & Chief Legal Officer | Sale 10b5-1 | −1,200 | $231.83 | $278K | 51,549 |
| 2026-06-03 | GALA RENEE D President & CEO | Gift | −600 | 152,196 |
Page 4 of 19 · 365 trades